The First Department of Gastrointestinal Oncology, Linfen Central Hospital: Precision Therapy, Rebirth of the Jedi

“If it wasn’t for the high medical skills of the doctors, my life would definitely be gone now.” A few days ago, Mr. Feng, who was undergoing immune maintenance therapy in the Department of Gastrointestinal Oncology, Linfen Central Hospital, praised the Central Hospital for everyone. Comprehensive strength.

Mr. Feng has a history of hepatitis B for more than ten years, and has not had regular regular examinations and treatment in recent years. In addition, Mr. Feng also likes to drink some wine with three meals a day, and also drinks to help sleep when the work pressure is heavy. In February 2021, during a routine physical examination organized by the unit, it was found that alpha-fetoprotein was abnormally increased, and abdominal MRI showed liver mass. So I went to the outpatient clinic of Li Yanli, director of the First Division of Digestive Oncology.

After being admitted to the hospital, after liver biopsy and immunological examination, Mr. Feng was finally diagnosed with stage III primary liver cancer. What’s more unfortunate is that the tumor diameter is large, and Mr. Feng’s hepatitis B has developed into liver cirrhosis, which is not suitable for surgical resection.

Li Yanli has conducted joint consultations with ultrasound, imaging, pathology, surgery, internal medicine, radiotherapy, interventional departments, etc., combined with the new precision treatment concept in the field of liver cancer treatment in the past two years, after careful analysis and analysis. Evaluation, and finally formulated a comprehensive anti-tumor treatment plan of intervention + targeting + radiofrequency ablation + immunotherapy for Mr. Feng.

From March 1 to April 14, 2021, after two courses of targeted therapy plus immunotherapy, Mr. Feng’s tumor shrank significantly, and he was transferred to the Interventional Department for liver cancer intervention on April 20, 2021 Embolization therapy.

But another problem followed. Mr. Feng’s portal pressure increased significantly, splenomegaly, thrombocytopenia, hemoglobin reduction, and leukopenia. He was diagnosed with hypersplenism. “There are two conventional treatment methods for this disease, one is to remove the spleen, and the other is to embolize.” Li Yanli said that the former is traumatic, takes a long time to recover, and affects the quality of life after removal, so it is obviously not suitable for Mr. Feng now; the latter is Minimally invasive, efficient and safe, it can better solve the treatment problem of patients with splenomegaly and hypersplenism. In the end, Mr. Feng and his family received “splenic artery embolization” and underwent partial splenic artery embolization intervention on May 19, 2021.

In order to completely eliminate the tumor, on June 28, 2021, Mr. Feng, who is in stable condition, was transferred to the Department of Oncology for radiofrequency ablation of liver cancer. Under the guidance of CT, the radiofrequency ablation needle precisely reaches the core of the liver cancer, and superimposed ablation is given in stages to accurately “burn” the cancer cells, achieving the effect of clinical cure.

The multi-disciplinary combination of the central hospital, the precise treatment combining systemic treatment and local treatment, made Mr. Feng “reborn from the Jedi”. (Yan Yanhong, Linfen Daily)

Original title: Precision Therapy, Rebirth of the Jedi

[Editor: Xi Yawen]